Personalized image-guided radiotherapy with multidisciplinary approach in long-surviving oligo-metastatic prostate cancer patient: A case report

Elisabetta Garibaldi, Elena Delmastro, Domenico Gabriele, Monica Garibaldi, Valeria Pirro, Marcello Tucci, Sara Bresciani, Pietro Gabriele

Research output: Contribution to journalArticle

Abstract

We describe the case of an oligo-metastatic prostate cancer patient successfully treated over a period of 11 years, by radiotherapy and systemic therapies. The patient's clinical history began in 1999 when he was treated by radiotherapy on prostate bed and concurrent maximal androgen blockade (MAB). After an initial biochemical response, in 2004 he had a disease relapse in pelvic nodes and MAB was restarted. Due to persistence of disease in pelvic nodes, Docetaxel was started in February 2007, with a partial response and then in 2008 radiotherapy was performed on the pelvic node (with PSA decreasing <0.1 ng/mL). In April 2011 restaging showed metastasis in left adrenocortical gland and lumbar-aortic nodes: radiotherapy was performed, with good biochemical response. In April 2013 a metastases in a supraclavicular lymph node was found and Docetaxel was re-started, with good biochemical response. In October 2014 patient had a recurrence in the iliac and neck nodes. In December 2014 radiotherapy was performed, on bilateral positive submandibular nodes and left positive supraclavicular node, with concurrent Abiraterone acetate. At last follow-up (December 2015) PSA was 0.001 ng/mL.

Original languageEnglish
Pages (from-to)384-390
Number of pages7
JournalGazzetta Medica Italiana Archivio per le Scienze Mediche
Volume175
Issue number9
Publication statusPublished - Sep 1 2016

Fingerprint

Image-Guided Radiotherapy
docetaxel
Prostatic Neoplasms
Radiotherapy
Androgens
Neoplasm Metastasis
Recurrence
Prostate
Neck
Lymph Nodes

Keywords

  • Abiraterone acetate
  • Adrenocortical carcinoma
  • Image-guided radiotherapy
  • Neoplasm metastasis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{bd5e0e963449454bb2fd3d58949299da,
title = "Personalized image-guided radiotherapy with multidisciplinary approach in long-surviving oligo-metastatic prostate cancer patient: A case report",
abstract = "We describe the case of an oligo-metastatic prostate cancer patient successfully treated over a period of 11 years, by radiotherapy and systemic therapies. The patient's clinical history began in 1999 when he was treated by radiotherapy on prostate bed and concurrent maximal androgen blockade (MAB). After an initial biochemical response, in 2004 he had a disease relapse in pelvic nodes and MAB was restarted. Due to persistence of disease in pelvic nodes, Docetaxel was started in February 2007, with a partial response and then in 2008 radiotherapy was performed on the pelvic node (with PSA decreasing <0.1 ng/mL). In April 2011 restaging showed metastasis in left adrenocortical gland and lumbar-aortic nodes: radiotherapy was performed, with good biochemical response. In April 2013 a metastases in a supraclavicular lymph node was found and Docetaxel was re-started, with good biochemical response. In October 2014 patient had a recurrence in the iliac and neck nodes. In December 2014 radiotherapy was performed, on bilateral positive submandibular nodes and left positive supraclavicular node, with concurrent Abiraterone acetate. At last follow-up (December 2015) PSA was 0.001 ng/mL.",
keywords = "Abiraterone acetate, Adrenocortical carcinoma, Image-guided radiotherapy, Neoplasm metastasis",
author = "Elisabetta Garibaldi and Elena Delmastro and Domenico Gabriele and Monica Garibaldi and Valeria Pirro and Marcello Tucci and Sara Bresciani and Pietro Gabriele",
year = "2016",
month = "9",
day = "1",
language = "English",
volume = "175",
pages = "384--390",
journal = "Gazzetta Medica Italiana Archivio per le Scienze Mediche",
issn = "0393-3660",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "9",

}

TY - JOUR

T1 - Personalized image-guided radiotherapy with multidisciplinary approach in long-surviving oligo-metastatic prostate cancer patient

T2 - A case report

AU - Garibaldi, Elisabetta

AU - Delmastro, Elena

AU - Gabriele, Domenico

AU - Garibaldi, Monica

AU - Pirro, Valeria

AU - Tucci, Marcello

AU - Bresciani, Sara

AU - Gabriele, Pietro

PY - 2016/9/1

Y1 - 2016/9/1

N2 - We describe the case of an oligo-metastatic prostate cancer patient successfully treated over a period of 11 years, by radiotherapy and systemic therapies. The patient's clinical history began in 1999 when he was treated by radiotherapy on prostate bed and concurrent maximal androgen blockade (MAB). After an initial biochemical response, in 2004 he had a disease relapse in pelvic nodes and MAB was restarted. Due to persistence of disease in pelvic nodes, Docetaxel was started in February 2007, with a partial response and then in 2008 radiotherapy was performed on the pelvic node (with PSA decreasing <0.1 ng/mL). In April 2011 restaging showed metastasis in left adrenocortical gland and lumbar-aortic nodes: radiotherapy was performed, with good biochemical response. In April 2013 a metastases in a supraclavicular lymph node was found and Docetaxel was re-started, with good biochemical response. In October 2014 patient had a recurrence in the iliac and neck nodes. In December 2014 radiotherapy was performed, on bilateral positive submandibular nodes and left positive supraclavicular node, with concurrent Abiraterone acetate. At last follow-up (December 2015) PSA was 0.001 ng/mL.

AB - We describe the case of an oligo-metastatic prostate cancer patient successfully treated over a period of 11 years, by radiotherapy and systemic therapies. The patient's clinical history began in 1999 when he was treated by radiotherapy on prostate bed and concurrent maximal androgen blockade (MAB). After an initial biochemical response, in 2004 he had a disease relapse in pelvic nodes and MAB was restarted. Due to persistence of disease in pelvic nodes, Docetaxel was started in February 2007, with a partial response and then in 2008 radiotherapy was performed on the pelvic node (with PSA decreasing <0.1 ng/mL). In April 2011 restaging showed metastasis in left adrenocortical gland and lumbar-aortic nodes: radiotherapy was performed, with good biochemical response. In April 2013 a metastases in a supraclavicular lymph node was found and Docetaxel was re-started, with good biochemical response. In October 2014 patient had a recurrence in the iliac and neck nodes. In December 2014 radiotherapy was performed, on bilateral positive submandibular nodes and left positive supraclavicular node, with concurrent Abiraterone acetate. At last follow-up (December 2015) PSA was 0.001 ng/mL.

KW - Abiraterone acetate

KW - Adrenocortical carcinoma

KW - Image-guided radiotherapy

KW - Neoplasm metastasis

UR - http://www.scopus.com/inward/record.url?scp=84989832267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989832267&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84989832267

VL - 175

SP - 384

EP - 390

JO - Gazzetta Medica Italiana Archivio per le Scienze Mediche

JF - Gazzetta Medica Italiana Archivio per le Scienze Mediche

SN - 0393-3660

IS - 9

ER -